Prudential plc (“Prudential”) and Icon Cancer Centre Singapore (“Icon”) today announced a partnership that will provide Prudential’s health customers in Singapore and Indonesia access to outpatient cancer treatment, on a cashless basis1, at Icon’s clinics in Singapore.
Read also – The ePlane Company Secures $14 Mn Series B Funding
Treatments that are covered include chemotherapy, immunotherapy, targeted therapy, radiotherapy and surgical oncology*. In addition to prescribed cancer drugs, Icon’s clinics can provide Prudential customers with access to a team of leading oncologists and haematologists.
Read also – ADB Financing to Promote Green Development, Drinking Water Security in Nepal
Customers based in Singapore can also make use of Icon’s diagnostic screening facility. Prudential’s customers in Indonesia who wish to receive their treatment overseas can choose any preferred clinic from the Icon Cancer Centre network in Singapore without having to pay out of pocket.
In Southeast Asia, more than 2.3 million people are diagnosed with cancer each year1. In Singapore, cancer incidence rates have risen by almost 28 per cent over the last 50 years2. For Indonesia, the same trend is observed with a 17 per cent increase of new diagnoses from 2020 to 20223.
“At Prudential, our focus is on providing affordable access to quality care for our customers. Receiving a cancer diagnosis can be life-changing and overwhelming, and questions about where to seek treatment and its cost only add to patients’ anxiety. Integrating Icon into Prudential’s preferred partnership network enables our customers to easily access a specialist cancer centre with proven expertise in treating many types of cancers without having to pay out of pocket,” said Arjan Toor, CEO, Health at Prudential plc.
“We have launched this partnership for the benefit of our customers in Singapore and Indonesia, two priority markets for our Health business, where we see growing demand for health insurance as well as an increasing volume of medical claims. We are looking to extend this access to other markets so more of our customers can benefit from high-quality cancer care,” said Toor.
“Icon is pleased to partner with Prudential to enhance access to high-quality cancer care, diagnosis, and treatment. Together, we are dedicated to making a lasting impact on cancer care and improving outcomes for patients. This partnership will help ease the burden for patients and their families, relieving some of the stress that comes with a cancer diagnosis and allowing them to focus on their treatment and wellbeing,” said Serena Wee, CEO, Icon Cancer Centre – ASEAN.
- In Singapore, customers holding the PRUExtra Premier, PRUExtra Premier CoPay and PRUExtra Preferred
- CoPay plans are eligible under PRUPanel Connect (PPC) for cashless medical services at Icon through an enhanced electronic letter of guarantee or pre-authorisation.
About Prudential plc
Prudential plc provides life and health insurance and asset management in 24 markets across Asia and Africa. Prudential’s mission is to be the most trusted partner and protector for this generation and generations to come, by providing simple and accessible financial and health solutions. The business has dual primary listings on the Stock Exchange of Hong Kong (2378) and the London Stock Exchange (PRU). It also has a secondary listing on the Singapore Stock Exchange (K6S) and a listing on the New York Stock Exchange (PUK) in the form of American Depositary Receipts. It is a constituent of the Hang Seng Composite Index and is also included for trading in the Shenzhen-Hong Kong Stock Connect programme and the Shanghai-Hong Kong Stock Connect programme.
Prudential is not affiliated in any manner with Prudential Financial, Inc. a company whose principal place of business is in the United States of America, nor with The Prudential Assurance Company Limited, a subsidiary of M&G plc, a company incorporated in the United Kingdom.
About Icon Group
Icon Group is Australia’s largest integrated provider of cancer care with a growing reach in New Zealand, Asia and the United Kingdom.
Icon is built on a strong but simple mission – to deliver the best care possible to as many people as possible, as close to home as possible. The group brings together all aspects of quality cancer care including medical oncology, haematology, radiation oncology, research, theranostics, pharmacy and compounding to deliver a truly integrated, end-to-end seamless service for cancer patients. With more than 3,500 team members, a network of more than 350 doctors, more than 45 cancer centres, six compounding facilities and operational support of 70 plus pharmacies, Icon is delivering world-leading care and helping address the global cancer burden.
About Icon Cancer Centre – Singapore
Icon Cancer Centre is a leading private cancer care provider delivering a holistic approach to cancer care. Icon Cancer Centre is part of Icon Group, a global cancer care provider with more than 45 centres globally. Icon Cancer Centre has six specialist clinics in Singapore and a dedicated health screening clinic. With a prominent and experienced team of medical oncologists, radiation oncologists, haematologists, paediatric haematologist-oncologists, palliative care specialists, general practitioners and visiting surgical oncologists, Icon provides end-to-end cancer care from screening and diagnosis, through to treatment and beyond.
